CDC Financial »

C4 Therapeutics shares owned by CDC Financial

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by CDC Financial from 13F filings

Historical chart of CDC Financial investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by CDC Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by CDC Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7k 1.0k 4.67

More positions owned by CDC Financial

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Inhibrx Biosciences (INBX)
Health Catalyst (HCAT)
Legalzoom (LZ)
Amplify Energy Corp (AMPY)
Atlas Energy Solutions Com New (AESI)
Immersion Corporation (IMMR)
Century Aluminum Company (CENX)
Vox Rty Corp Cda F (VOXR)
Algoma Stl Group (ASTL)
Humana Put Option (HUM)
Afc Gamma Ord (AFCG)
Turtle Beach Corp Com New (TBCH)

View all positions for CDC Financial

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
BlackRock
Squadron Capital Management
Lynx1 Capital Management
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Goldman Sachs Group
Daniel D. Thurber
Two Sigma Investments
Soleus Capital Management
Silverarc Capital Management
Bank of America Corporation

View all funds holding C4 Therapeutics